Compaq
Been spending a lot of time on here!
- Joined
- Aug 29, 2010
- Messages
- 3,400
- Reaction score
- 657
- Location
- Norway
- Can others edit my Photos
- Photos OK to edit
This is my most recent edit. The only thing left now is carefully look for typos.
Writing is personal. Getting critique on your writing is like getting critique on your photos: The defensive position is easily assumed. I have worked on this essay for five weeks, and weekly gotten invaluable feedback.
Science Needs Animal-Testing
Medical research benefits humans greatly. Decades of medical studies has made
several diseases treatable, such as diebetis, tuberculosis, and malaria. Moreover,
medical research has prevented altogether diseases such as hepatitis A and B,
measles, and poliomyelitis. Common for all these developments is animal-testing
(Quimby, 1998). While testing on animals is not morally ideal, we lack good
alternatives. Thus, abandoning animal-testing is premature, because medical
research needs complex-system test-subjects, and the absence of which can be
risky for pharmaceutical consumers.
Animal testing has helped develope new medicine. Almost all research in
medicine awarded with the Nobel Prize have used animal-testing (Foundation
for Biomedical Research, nd). One example of this is the polio-vaccine. En-
ders's group's research on poliomyelitis, which used mice and monkeys, won the
Nobel Prize in 1954, and is considered the breakthrough in polio-research (En-
ders et al., 1980). Later that decade, Sabin developed the oral polio-vaccine.
Sabin states in a publication (1956) that, thus far, research has demanded circa
133 human volunteers, 9000 monkeys, and 150 chimpanzees in poliovirus-strain
studies.
Because of extensive polio-research, many lives have been saved. WHO writes
in fact sheet #114 (2012) that the polio-vaccine has prevented 10 million people
from paralizis and saved 1.5 million childhood lives. Polio-research has clearly
benefitted humans massively, which animal-testing has helped achieve.
As well as having helped develop medicine, American history shows that animal-
testing can reduce the risk of mass-poisoning as well. Sulfanilamide was a drug
used for streptococcal infections, existing as tablets or powder. S.E. Massen-
gill Company of Bristol wanted to develop a liquid preparate, and discovered
that diethylene glycol had satisfactory chemical and physical poperties. The
company did no testing of what they called "Elixir Sulfanilamide" before distri-
bution. Diethylene glycol is toxic unless treated, and 105 patients died (Wax,
1995). Had the drug been tested on animals, its toxicity would be observed,
and deaths prevented.
The moral questions of animal-testing, raised by animal-rights organizations, are
important. Animals suffer and die in some scientific experiments, which triggers
a moral response. Animal Aid, UK's largest animal-rights organization, claims
that animals "[...]die not only cruelly but in vain." (Animal Aid, nda). They
also claim to have found, in an undercover investigation, "[...]researchers laugh-
ing as they smashed live mice against bench tops to kill them." (Animal Aid,
ndb). Thus, there are strong, moral arguments against animal-testing.
However, strict legislation is implemented in many countries. One cannot use
animals unless all other methods are inapplicable - and their use, when allowed,
is governed. Institutions follow the three "R"'s: Replacing, reducing and re-
ning animal usage (Festing and Wilkinson, 2007). The UK has gone very
far with these laws. The Animals Act (1986), demands that everyone plan-
ning to use animals scientifically must carefully assess exactly how the animals
will suffer, what sorts of animals they will use, and how many. Further, they
must evaluate the costs and benets of the animals' role. In addition, after the
Freedom of Information Act (2005) was implemented, everyone can request
information from public bodies. This promotes openness, public understanding
of decision-making and spendatures, and accountability (Festing and Wilkinson,
2007). Countries try to govern animal use as best as possible, to minimize the
unnecessary suffering of animals. Thus, animal-rights organizations ought to
acknowledge animal-testing's contribution to scientific knowledge, even respect
it, and stop monsterizing researchers.
Indeed, in an ideal world, no animal-testing would happen. However, until an-
imals can be fully replaced as test-subjects, there must be good alternatives.
To effectively assess a new drug's toxicity, it is vital to know how the drug be-
haves in complex systems. The differences between humans and animals have
not helped develop new medicine, but the similarities among vertabrates have.
Many investigations can be carried out with mathematical modelations, or in
vitro studies, but when the interest is drug-activity in multi-organ organisms,
living animals is still the best choice (Quimby, 1998).
In conclusion, until there are good alternatives, animal-testing must prevail.
Animal-testing has helpedus in the past, and its absence has cost us. Moral
concerns are important, but not ignored. In the future, animal-rights organi-
zations should promote research for alternative methods, and bring attention
to this research field.
References
Animal Aid (n.d.a). Betrayed - the silent suf-
ferings of cats and dogs. Retrieved 11/4-12:
[Animal Aid: BETRAYED - The Silent Suffering of Cats and Dogs].
Animal Aid (n.d.b). Killing animals and humans. Retrieved 11/4-12:
[Animal Aid: Killing animals and humans].
Enders, J. F., Robbins, F. C., and Weller, T. H. (1980). The cultivation of
the poliomyelitis viruses in tissue culture. Reviews of Infectious Diseases,
2(3):493-504. Nobel Lecture, held on 11 December 1954, Karolinska Institute,
Stockholm, Sweden.
Festing, S. and Wilkinson, R. (2007). The ethics of animal research. Talking
point on the use of animals in scientific research. EMBO Reports, 8(6):526-530.
Foundation for Biomedical Research (n.d.). Nobel prize. Retrieved 16/4-13:
[http://www.fbresearch.org/nobelprize/].
Quimby, F. (1998). Contributions to veterinary medicine from animal research.
Applied Animal Behavior Science, 59(1-3):183-192.
Sabin, A. B. (1956). Present status of attenuated live-virus poliomyelitis vaccine.
Journal of the American Medical Association, 162(18):1589-1596.
Wax, P. M. (1995). Elixirs, diluents, and the passage of the 1938 federal food,
drug and cosmetic act. Annals of Internal Medicine, 122(6):456-461.
World Health Organization (2012). Poliomyelitis. Retrieved 10/4-13:
[http://www.who.int/mediacentre/factsheets/fs114/en/].
Writing is personal. Getting critique on your writing is like getting critique on your photos: The defensive position is easily assumed. I have worked on this essay for five weeks, and weekly gotten invaluable feedback.
Science Needs Animal-Testing
Medical research benefits humans greatly. Decades of medical studies has made
several diseases treatable, such as diebetis, tuberculosis, and malaria. Moreover,
medical research has prevented altogether diseases such as hepatitis A and B,
measles, and poliomyelitis. Common for all these developments is animal-testing
(Quimby, 1998). While testing on animals is not morally ideal, we lack good
alternatives. Thus, abandoning animal-testing is premature, because medical
research needs complex-system test-subjects, and the absence of which can be
risky for pharmaceutical consumers.
Animal testing has helped develope new medicine. Almost all research in
medicine awarded with the Nobel Prize have used animal-testing (Foundation
for Biomedical Research, nd). One example of this is the polio-vaccine. En-
ders's group's research on poliomyelitis, which used mice and monkeys, won the
Nobel Prize in 1954, and is considered the breakthrough in polio-research (En-
ders et al., 1980). Later that decade, Sabin developed the oral polio-vaccine.
Sabin states in a publication (1956) that, thus far, research has demanded circa
133 human volunteers, 9000 monkeys, and 150 chimpanzees in poliovirus-strain
studies.
Because of extensive polio-research, many lives have been saved. WHO writes
in fact sheet #114 (2012) that the polio-vaccine has prevented 10 million people
from paralizis and saved 1.5 million childhood lives. Polio-research has clearly
benefitted humans massively, which animal-testing has helped achieve.
As well as having helped develop medicine, American history shows that animal-
testing can reduce the risk of mass-poisoning as well. Sulfanilamide was a drug
used for streptococcal infections, existing as tablets or powder. S.E. Massen-
gill Company of Bristol wanted to develop a liquid preparate, and discovered
that diethylene glycol had satisfactory chemical and physical poperties. The
company did no testing of what they called "Elixir Sulfanilamide" before distri-
bution. Diethylene glycol is toxic unless treated, and 105 patients died (Wax,
1995). Had the drug been tested on animals, its toxicity would be observed,
and deaths prevented.
The moral questions of animal-testing, raised by animal-rights organizations, are
important. Animals suffer and die in some scientific experiments, which triggers
a moral response. Animal Aid, UK's largest animal-rights organization, claims
that animals "[...]die not only cruelly but in vain." (Animal Aid, nda). They
also claim to have found, in an undercover investigation, "[...]researchers laugh-
ing as they smashed live mice against bench tops to kill them." (Animal Aid,
ndb). Thus, there are strong, moral arguments against animal-testing.
However, strict legislation is implemented in many countries. One cannot use
animals unless all other methods are inapplicable - and their use, when allowed,
is governed. Institutions follow the three "R"'s: Replacing, reducing and re-
ning animal usage (Festing and Wilkinson, 2007). The UK has gone very
far with these laws. The Animals Act (1986), demands that everyone plan-
ning to use animals scientifically must carefully assess exactly how the animals
will suffer, what sorts of animals they will use, and how many. Further, they
must evaluate the costs and benets of the animals' role. In addition, after the
Freedom of Information Act (2005) was implemented, everyone can request
information from public bodies. This promotes openness, public understanding
of decision-making and spendatures, and accountability (Festing and Wilkinson,
2007). Countries try to govern animal use as best as possible, to minimize the
unnecessary suffering of animals. Thus, animal-rights organizations ought to
acknowledge animal-testing's contribution to scientific knowledge, even respect
it, and stop monsterizing researchers.
Indeed, in an ideal world, no animal-testing would happen. However, until an-
imals can be fully replaced as test-subjects, there must be good alternatives.
To effectively assess a new drug's toxicity, it is vital to know how the drug be-
haves in complex systems. The differences between humans and animals have
not helped develop new medicine, but the similarities among vertabrates have.
Many investigations can be carried out with mathematical modelations, or in
vitro studies, but when the interest is drug-activity in multi-organ organisms,
living animals is still the best choice (Quimby, 1998).
In conclusion, until there are good alternatives, animal-testing must prevail.
Animal-testing has helpedus in the past, and its absence has cost us. Moral
concerns are important, but not ignored. In the future, animal-rights organi-
zations should promote research for alternative methods, and bring attention
to this research field.
References
Animal Aid (n.d.a). Betrayed - the silent suf-
ferings of cats and dogs. Retrieved 11/4-12:
[Animal Aid: BETRAYED - The Silent Suffering of Cats and Dogs].
Animal Aid (n.d.b). Killing animals and humans. Retrieved 11/4-12:
[Animal Aid: Killing animals and humans].
Enders, J. F., Robbins, F. C., and Weller, T. H. (1980). The cultivation of
the poliomyelitis viruses in tissue culture. Reviews of Infectious Diseases,
2(3):493-504. Nobel Lecture, held on 11 December 1954, Karolinska Institute,
Stockholm, Sweden.
Festing, S. and Wilkinson, R. (2007). The ethics of animal research. Talking
point on the use of animals in scientific research. EMBO Reports, 8(6):526-530.
Foundation for Biomedical Research (n.d.). Nobel prize. Retrieved 16/4-13:
[http://www.fbresearch.org/nobelprize/].
Quimby, F. (1998). Contributions to veterinary medicine from animal research.
Applied Animal Behavior Science, 59(1-3):183-192.
Sabin, A. B. (1956). Present status of attenuated live-virus poliomyelitis vaccine.
Journal of the American Medical Association, 162(18):1589-1596.
Wax, P. M. (1995). Elixirs, diluents, and the passage of the 1938 federal food,
drug and cosmetic act. Annals of Internal Medicine, 122(6):456-461.
World Health Organization (2012). Poliomyelitis. Retrieved 10/4-13:
[http://www.who.int/mediacentre/factsheets/fs114/en/].